Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Thomas, Dewar"'
Autor:
Ernest T. Hawk, Thomas Sylwestrowicz, Bruce Salzberg, John R. Saltzman, Ronald E. Pruitt, Finlay Macrae, Neville Hoffman, T. Raymond Foley, Thomas Dewar, Daniel C. Chung, John Burn, Neal T. Collins, Donya Bagheri, Asad Umar, Rebecca B. Rosenstein, Jie Tang, KyungMann Kim, Aurora Breazna, Mark Redston, Ann G. Zauber, Craig J. Eagle, Monica M. Bertagnolli
Perspective on this Article from Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3113a9c54a3b7bfd7fdaece3096f1cd6
https://doi.org/10.1158/1940-6207.22523892.v1
https://doi.org/10.1158/1940-6207.22523892.v1
Autor:
Ernest T. Hawk, Thomas Sylwestrowicz, Bruce Salzberg, John R. Saltzman, Ronald E. Pruitt, Finlay Macrae, Neville Hoffman, T. Raymond Foley, Thomas Dewar, Daniel C. Chung, John Burn, Neal T. Collins, Donya Bagheri, Asad Umar, Rebecca B. Rosenstein, Jie Tang, KyungMann Kim, Aurora Breazna, Mark Redston, Ann G. Zauber, Craig J. Eagle, Monica M. Bertagnolli
Supplementary Information from Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a7ca1e0fef4a828ff27e5e81d4b65d8
https://doi.org/10.1158/1940-6207.22523889.v1
https://doi.org/10.1158/1940-6207.22523889.v1
Autor:
Monica M, Bertagnolli, Craig J, Eagle, Ann G, Zauber, Mark, Redston, Aurora, Breazna, Kyungmann, Kim, Jie, Tang, Rebecca B, Rosenstein, Asad, Umar, Donya, Bagheri, Neal T, Collins, John, Burn, Daniel C, Chung, Thomas, Dewar, T Raymond, Foley, Neville, Hoffman, Finlay, Macrae, Ronald E, Pruitt, John R, Saltzman, Bruce, Salzberg, Thomas, Sylwestrowicz, Ernest T, Hawk, S J, Van Zantan
Publikováno v:
Cancer prevention research (Philadelphia, Pa.). 2(4)
The Adenoma Prevention with Celecoxib Trial examined the efficacy and safety of the cyclooxygenase (Cox)-2 inhibitor, celecoxib, for sporadic colorectal adenoma prevention in patients at high risk for colorectal cancer. The trial randomized 2,035 sub
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4fec83a7b704ac8877aa537ad2ec26b
https://pubmed.ncbi.nlm.nih.gov/19336723
https://pubmed.ncbi.nlm.nih.gov/19336723
Autor:
Timothy Hess, Gary Gordon, Scott D. Solomon, Monica M. Bertagnolli, Kyung Mann Kim, Craig J. Eagle, Ann G. Zauber, G. Mabel Woloj, Donya Bagheri, Ernest T. Hawk, Frédéric Boisserie, Janet Wittes, Rebecca B. Rosenstein, Bruce Salzberg, Thomas Dewar, William F. Anderson, Jaye L. Viner, T. Raymond Foley, Finlay A. Macrae, Jie Tang, Donald K. Corle, Daniel C. Chung, John Burn, Thomas Sylwestrowicz, Neville E. Hoffman, John R. Saltzman, Ronald E. Pruitt, Mark Redston
Publikováno v:
The New England journal of medicine. 355(9)
Studies showing that drugs that inhibit cyclooxygenase-2 (COX-2) reduce the number of colorectal adenomas in animals and patients with familial adenomatous polyposis suggest that COX-2 inhibitors may also prevent sporadic colorectal neoplasia.We rand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01a1753d671be04983c16cbafb9c2aa9
https://pubmed.ncbi.nlm.nih.gov/17135594
https://pubmed.ncbi.nlm.nih.gov/17135594
Autor:
C. P. S., Thomas Dewar Weldon
Publikováno v:
Harvard Law Review. 61:918
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c63316ec03a383e1c5259a2c761b721
https://doi.org/10.2307/1336368
https://doi.org/10.2307/1336368